Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Bharat Serums And Vaccines Limited, is an unlisted public company incorporated on 11 November, 1993. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 1,167.16 cr and the total paid-up capital is INR 73.09 lac.
Bharat Serums And Vaccines Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2024. It's EBITDA has increased by 51.86% over the previous year. At the same time, it's book networth has increased by 2.26%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Sanjiv Hari Navangul | 02924640 | 6 years |
| Additional Director | Bharat Anand | 02806475 | 1 years |
| Additional Director | Satish Kumar Sharma | 07615602 | 0 years |
| Additional Director | Anju Kumari Jha | 08141260 | 1 years |
| Additional Director | Rajeev Juneja | 00283481 | 1 years |
| Additional Director | Sheetal Arora | 00704292 | 1 years |
| Additional Director | Arjun Juneja | 00704349 | 1 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CitiBank N.A.
No. of Loans: 3
Total Amount : 410.0 cr
ICICI Bank Limited
No. of Loans: 2
Total Amount : 85.8 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 65.0 cr
IDBI Bank Limited
No. of Loans: 1
Total Amount : 35.0 cr
The Hongkong and Shanghai Banking Corporation Limited
No. of Loans: 1
Total Amount : 25.0 cr
DBS BANK INDIA LIMITED
No. of Loans: 1
Total Amount : 25.0 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 6.0 cr
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| BSV PHARMA PRIVATE LIMITED | India | - | - |
| BSV Bioscience GmbH | Germany | - | - |
| BSV Biosciences Inc. | United States | - | - |
| BSV Bioscience Malaysia Sdn. Bhd. | Malaysia | - | - |
| Genomicks Sdn. Bhd. | Malaysia | - | - |
| BSV Bioscience Philippines Inc. | Philippines | - | - |
Read more
The incorporation date of BHARAT SERUMS AND VACCINES LIMITED is 11 November, 1993
The authorized share capital of BHARAT SERUMS AND VACCINES LIMITED is INR ₹ 1,167.2 Cr.
The paid-up capital of BHARAT SERUMS AND VACCINES LIMITED is INR ₹ 73.1 L.
The registered address of BHARAT SERUMS AND VACCINES LIMITED is 3rd Floor, Liberty Tower, Plot No. K-10, Behind Reliable Plaza, Kalwa Industrial Estate, Airoli, Thane, Thane, Maharashtra, India, 400708 - 400708
The CIN number of BHARAT SERUMS AND VACCINES LIMITED is U74110MH1993PLC075088.